BG Medicine's Q2 Revenues Plunge 47 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BG Medicine today said that second-quarter revenues dropped 47 percent year over year due to decreased activity in a project begun a few years ago to develop diagnostic biomarkers for heart attacks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.